Clinical trial

Laser Photocoagulation and Ranibizumab Treatment in Proliferative Diabetic Retinopathy

NCT07819253

Drugs and interventions used in this trial

2 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DRUG · Unmapped registry intervention Ranibizumab 0.5 mg Find medicine records · Find other trials using this name

PROCEDURE · Unmapped registry intervention laser photocoagulation (PRP) Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

Laser Photocoagulation and Ranibizumab Treatment in Proliferative Diabetic Retinopathy

Design: INTERVENTIONAL · Status: COMPLETED · Phase: NA

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2023-07-01

PhaseNA

Conditions

Proliferative Diabetic Retinopathy (PDR)unresolved

Interventions

Ranibizumab 0.5 mgDRUG

laser photocoagulation (PRP)PROCEDURE

Sponsors & collaborators

Aswan Universitylead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT07819253 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.